Menu Back to DIA-FDA-Statistics-Forum-2014

Program Committee

  • Joan  Buenconsejo
    Joan Buenconsejo Statistics Team Leader, Inflammation, Neuroscience & Respiratory TA, B&I Science AstraZeneca Pharmaceuticals LP, United States
  • Walter  Offen, PhD
    Walter Offen, PhD Global Head of Statistical Innovation & Safety Statistics AbbVie Inc, United States
  • Christy  Chuang-Stein, PhD
    Christy Chuang-Stein, PhD Vice President, Head of Statistical Research and Consulting Center Pfizer Inc., United States
  • Brenda  Crowe, PhD
    Brenda Crowe, PhD Senior Research Advisor, Global Statistical Sciences Eli Lilly and Company, United States
  • Jose C. Pinheiro, PhD
    Jose C. Pinheiro, PhD Senior Director, Quantitative Decision Strategies Janssen Research & Development, LLC, United States
  • Estelle  Russek-Cohen, PhD
    Estelle Russek-Cohen, PhD Director, Division of Biostatistics, OBE, CBER FDA, United States
  • Barry H. Schwab, PhD
    Barry H. Schwab, PhD Vice President, Clinical Biostatistics Janssen Research & Development, LLC, United States
  • Jerald S. Schindler, DrPH
    Jerald S. Schindler, DrPH Vice President, Biostatistics and Research Decision Sciences Merck Research Laboratories, United States
  • Ram  Tiwari, PhD
    Ram Tiwari, PhD Associate Director, Office of Biostatistics, OTS, CDER FDA, United States
  • Joachim  Vollmar, MSc
    Joachim Vollmar, MSc Executive Consultant International Clinical Development Consultants LLC (ICDC), United States
  • Stephen E. Wilson, DrPH
    Stephen E. Wilson, DrPH Director, Division of Biometrics III, Office of Biostatistics, OTS, CDER FDA, United States
Load More